Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction

Autor: Grabner M, Burchard J, Nguyen C, Chung H, Gangan N, Boniface JJ, Zupancic JAF, Stanek E

Publikováno v: ClinicoEconomics and Outcomes Research, Vol Volume 13, Pp 809-820 (2021)

Michael Grabner,1 Julja Burchard,2 Chi Nguyen,3 Haechung Chung,4 Nilesh Gangan,3 J Jay Boniface,2 John AF Zupancic,5 Eric Stanek1 1Scientific Affairs, HealthCore, Inc., Wilmington, DE, USA; 2Research and Development, Sera Prognostics, Salt Lake City,

Externí odkaz: https://doaj.org/article/308578767345433998ee6009b17b830b

Clinical and economic burden of first-line chemoimmunotherapy by risk status in chronic lymphocytic leukemia.

Autor: Leslie LA; John Theurer Cancer Center, Hackensack, NJ, USA., Gangan N; HealthCore Inc, Wilmington, DE, USA., Tan H; HealthCore Inc, Wilmington, DE, USA., Huang Q; Janssen Scientific Affairs, LLC, Horsham, PA, USA.

Publikováno v: Current medical research and opinion [Curr Med Res Opin] 2022 Dec; Vol. 38 (12), pp. 2149-2161. Date of Electronic Publication: 2022 Oct 22.

EE342 Development of a Markov Model for Assessing the Cost-Effectiveness of Chronic Weight Management Interventions.

Autor: Richard, E¹ (AUTHOR), Gangan, N¹ (AUTHOR), Ketkar, AG¹ (AUTHOR), Grabner, M¹ (AUTHOR), Gabler, N¹ (AUTHOR), Head, M.A.¹ (AUTHOR), Smith, JL¹ (AUTHOR)

Publikováno v: Value in Health. 2024 Supplement, Vol. 27 Issue 6, pS120-S120. 1p.

MSR11 A Step-By-Step Guide for Causal Study Design When Estimating Treatment Effects Using Real-World Data

Autor: Hoffman, S, Gangan, N, Chen, X, Smith, JL, Tave, A, Yang, Y, Dosreis, S, Grabner, M

Publikováno v: In Value in Health July 2022 25(7) Supplement:S519-S519

PIH7 Cost-Effectiveness of a Proteomic Test for Preterm Birth Prediction

Autor: Grabner, M., Burchard, J., Nguyen, C., Chung, H., Gangan, N., Boniface, J., Zupancic, J.A.F., Stanek, E.

Publikováno v: In Value in Health June 2021 24 Supplement 1:S100-S100